Trinity Biotech (TRIB) Net Income towards Common Stockholders (2009 - 2024)
Trinity Biotech (TRIB) posted Net Income towards Common Stockholders of -$17.0 million for Q4 2024, down 256.27% sequentially from -$4.8 million in Q3 2024, and down 208.16% YoY from $15.7 million in Q1 2024.
Trinity Biotech (TRIB) Net Income towards Common Stockholders (2009 - 2024) Analysis & Trends
Trinity Biotech has reported Net Income towards Common Stockholders for 16 years, with the latest figure at -$17.0 million in Q4 2024.
- Quarterly Net Income towards Common Stockholders fell 208.16% year-over-year to -$17.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$21.7 million (up 31.69% YoY) and the FY2025 annual result came in at -$37.4 million, down 17.61% from the prior year.
- Net Income towards Common Stockholders retreated to -$17.0 million in Q4 2024 per TRIB's latest filing, from -$4.8 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $7.3 million in Q3 2020 and troughed at -$17.0 million in Q4 2024.
- A 5-year average of -$5.1 million and a median of -$5.7 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The widest YoY moves for Net Income towards Common Stockholders: up 29200.0% in 2020, down 1152183808.05% in 2020.
- Over 5 years, Net Income towards Common Stockholders stood at -$10.0 million in 2020, then surged by 87.39% to -$1.3 million in 2021, then sank by 697.47% to -$10.1 million in 2022, then jumped by 45.42% to -$5.5 million in 2023, then sank by 208.16% to -$17.0 million in 2024.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$17.0 million, -$4.8 million, and -$6.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -16.96 Mn |
| Sep 30, 2024 | -4.76 Mn |
| Jun 30, 2024 | -6.76 Mn |
| Mar 31, 2024 | -3.32 Mn |
| Dec 31, 2023 | -5.50 Mn |
| Sep 30, 2023 | -6.72 Mn |
| Jun 30, 2023 | -5.99 Mn |
| Mar 31, 2023 | -5.81 Mn |
| Dec 31, 2022 | -10.08 Mn |
| Sep 30, 2022 | -8.95 Mn |
| Jun 30, 2022 | -9.71 Mn |
| Mar 31, 2022 | -12.28 Mn |
| Dec 31, 2021 | -1.26 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | -783,000.00 |
| Mar 31, 2021 | 1.60 Mn |
| Dec 31, 2020 | -10.02 Mn |
| Sep 30, 2020 | 7.33 Mn |
| Jun 30, 2020 | -1.47 Mn |
| Mar 31, 2020 | -2.22 Mn |